Following FDA rejection, AstraZeneca finally gives up US rights to roxadustat

February 29, 2024

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

May 11, 2026

Roche Expands Obesity Pipeline with $1.65 Billion Zealand Pharma Partnership

March 18, 2025

Must Read

Pfizer and Innovent sign a $10 billion, 12-drug pact in a large wager on Chinese cancer medicine research

June 1, 2026

Agios Halts Tebapivat Development in LR-MDS After Phase 2b Trial Misses Primary Endpoint

June 1, 2026

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

May 22, 2026

About Us

Life Sciences Voice is the leading resource for life sciences executives to get crucial insights, explore the latest innovations, and learn about industry trends. Life Sciences Voice provides the community with thought-provoking commentary in multiple formats covering a range of issues from drug discovery to commercial success.

Kailera Details Nasdaq IPO Plans to Raise Up to $528.5 Million for Obesity Drug Development

Avalyn Files for IPO to Fund Late-Stage Development of Inhaled Lung Disease Therapies

Merck Pays $20 Million Upfront to Access Quotient’s Somatic Genomics Platform for IBD Research

Merck Gets $700M Funding From Blackstone For Cancer Therapy R&D

Agios Halts Tebapivat Development in LR-MDS After Phase 2b Trial Misses Primary Endpoint

Eli Lilly Reports Up to 28.3% Weight Loss in Phase 3 Retatrutide Obesity Trial

BioMarin Reports Phase 3 Growth Improvements for Voxzogo in Hypochondroplasia

Immunovant Forced to Pay Out to Scrap FcRn Inhibitor Following Phase 3 Failure

Pfizer and Innovent sign a $10 billion, 12-drug pact in a large wager on Chinese cancer medicine research

Incyte Expands Genesis AI Drug Discovery Partnership in Deal Worth Over $1 Billion

Novo Pens Deal With Cellular Intelligence to Advance Parkinson’s Cell Therapy

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

J&J MedTech presents the first Ottava surgical robot clinical cases

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

PicnicHealth Launches New Service Bringing Observational Clinical Trials to the Virtual Realm

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

The AI Talent War in Life Sciences Is Just Beginning

What Makes Life Sciences Data “AI-Ready”?

Synthetic Data in Healthcare: The Next Frontier or a Compliance Risk?

Clinical

Israel is examining Covid-19 vaccine related cases of myocarditis

Editor Picks

Following FDA rejection, AstraZeneca finally gives up US rights to roxadustat

CellCentric Raises $220 Million Series D to Advance Inobrodib and Launch Phase 3 Myeloma Trial

Roche Expands Obesity Pipeline with $1.65 Billion Zealand Pharma Partnership

Must Read

Pfizer and Innovent sign a $10 billion, 12-drug pact in a large wager on Chinese cancer medicine research

Agios Halts Tebapivat Development in LR-MDS After Phase 2b Trial Misses Primary Endpoint

How Smaller Biotech Firms Are Competing With Big Pharma Using AI

Hot Topics

About Us

Follow Us